Pharmaceutical industry + Government policy -- United States
Label
Pharmaceutical industry + Government policy -- United States
Name
Pharmaceutical industry + Government policy
Actions
Incoming Resources
- Subject of15
- Examining implementation of the Compounding Quality Act, hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 30, 2018
- Examining the actions of drug companies in raising prescription drug prices, hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019
- Analytical method guidance for the pharmaceutical manufacturing point source category
- Description of the revenue provisions of H.R. 3, the "Lower Drug Costs Now Act of 2019", scheduled for markup by the House Committee on Ways and Means on October 22, 2019, prepared by the staff of the Joint Committee on Taxation
- The fungal meningitis outbreak, could it have been prevented? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, November 14, 2012
- CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act, Christopher Adams and Evan Herrnstadt
- Profits over consumers, exposing how pharmaceutical companies game the system : hearing before the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, September 19, 2019
- Drug compounding: FDA authority and possible issues for Congress, other title information, Agata Dabrowska
- Guidance for industry, reports on the status of postmarketing study commitments : implementation of section 130 of the Food and Drug Administration Modernization Act of 1997
- Lower drug costs now, expanding access to affordable health care : hearing before the Subcommittee on Health, Employment, Labor, and Pensions of the Committee on Education and Labor, U.S. House of Representatives, One Hundred Seventeenth Congress, first session, hearing held in Washington, DC, May 5, 2021
- Priced out of a lifesaving drug, getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019
- A continuing investigation into the fungal meningitis outbreak and whether it could have been prevented, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 16, 2013
- Examining drug compounding, hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, May 23, 2013
- Lower Drug Costs Now Act of 2019, report of the Committee on Energy and Commerce
- The patient perspective, the devastating impacts of skyrocketing drug prices on American families : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, July 26, 2019